Abstract
Background
Head and neck cancer (HNC) and its treatment are associated with muscle weakness and considerable long-term comorbidity. The goal of this study was to determine whether skeletal muscle density (SMD) as quantified from pretreatment computed tomography (CT) scans will correlate with measures of function and strength prior to treatment in physical function in HNC patients.
Patients and methods
A cross-sectional analysis was conducted on 90 HNC patients. SMD (myosteatosis vs. normal) was calculated from pretreatment CT scans using SliceOmatic software. Pretreatment physical function was assessed via handgrip strength (HGS), the timed up and go test (TUG), and the short physical performance battery (SPPB). Demographic, cancer, and social characteristics were also collected as confounders. Linear regression models assessed the association between myosteatosis and measures of physical function.
Results
The 90 patients were predominately White, male, former smokers with an average BMI of 28.7 ± 5.7 kg/m2. Among men, adjusted models indicate, as compared to those with normal muscle density, the total SPPB score of those with myosteatosis was 1.57 points lower (p = 0.0008), HGS was 0.85 kg lower (p = 0.73), and TUG took 1.34 s longer (p = 0.03). There were no differences in women.
Conclusion
Myosteatosis is associated with physical function prior to treatment in HNC patients. Larger studies are needed to examine the importance of exercise programs prior to and during treatment to build lean mass and improve long-term prognosis in HNC.
Similar content being viewed by others
Data availability
Shaver, Platek, and Singh had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. The data underlying this article cannot be shared publicly for the privacy of individuals that participated in the study.
Code availability
All analyses were completed using SAS version 9.4.
References
Siegel RL et al (2021) Cancer statistics, 2021. CA: Cancer J Clin 71(1):7–33
Lucas AR et al (2020) Trajectories in muscular strength and physical function among men with and without prostate cancer in the health aging and body composition study. PLoS One 15(2):e0228773
Correa-de-Araujo R et al (2020) Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the national institute on aging. Front Physiol 11:963–963
Prado CMM, Heymsfield SB (2014) Lean tissue imaging: a new era for nutritional assessment and intervention. JPEN J Parenteral Enteral Nutr 38(8):940–953
Shen W et al (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) 97(6):2333–8
Findlay M et al (2020) Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost. J Hum Nutr Diet 33(6):811–821
Farrugia M et al (2021) Change in physical performance correlates with decline in quality of life and frailty status in head and neck cancer patients undergoing radiation with and without chemotherapy. Cancers (Basel) 13(7):1638
Brown JC, Harhay MO, Harhay MN (2015) Physical function as a prognostic biomarker among cancer survivors. Br J Cancer 112(1):194–198
Perera S et al (2006) Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 54(5):743–749
Pavasini R et al (2016) Short physical performance battery and all-cause mortality: systematic review and meta-analysis. BMC Med 14(1):215
Barbat-Artigas S et al (2013) Muscle quantity is not synonymous with muscle quality. J Am Med Dir Assoc 14(11):852.e1-852.e8527
Martín-Ponce E et al (2014) Prognostic value of physical function tests: hand grip strength and six-minute walking test in elderly hospitalized patients. Sci Rep 4:7530–7530
Cruz-Jentoft AJ et al (2019) Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31
Cesari M et al (2009) Added value of physical performance measures in predicting adverse health-related events: results from the health, aging and body composition study. J Am Geriatr Soc 57(2):251–259
Bohannon RW (2019) Grip strength: an indispensable biomarker for older adults. Clin Interv Aging 14:1681–1691
Forrest KYZ et al (2018) Patterns and correlates of grip strength in older Americans. Curr Aging Sci 11(1):63–70
Ha Y-C et al (2018) Hand grip strength measurement in different epidemiologic studies using various methods for diagnosis of sarcopenia: a systematic review. European Geriatric Medicine 9(3):277–288
Bischoff HA et al (2003) Identifying a cut-off point for normal mobility: a comparison of the timed ‘up and go’test in community-dwelling and institutionalised elderly women. Age Ageing 32(3):315–320
Cruz-Jentoft AJ et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31
Huisman MG et al (2014) “Timed Up & Go”: a screening tool for predicting 30-day morbidity in onco-geriatric surgical patients? A multicenter cohort study. PloS one 9(1):e86863–e86863
Agmon M, Armon G (2016) A cross-sectional study of the association between mobility test performance and personality among older adults. BMC Geriatr 16(1):105
Lydiatt W, O’Sullivan B, Patel S (2018) Major changes in head and neck staging for 2018. Am Soc Clin Oncol Educ Book 38:505–514
Amin M et al (2017) AJCC cancer staging manual, 8th edn. Springer, New York
Valentine RJ et al (2009) Sex impacts the relation between body composition and physical function in older adults. Menopause (New York, N.Y.) 16(3):518–523
Tseng LA et al (2014) Body composition explains sex differential in physical performance among older adults. J Gerontol Ser A Biol Sci Med Sci 69(1):93–100
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA: Cancer J Clin 70(1):7–30
Fryar CD et al (2018) Mean body weight, height, waist circumference, and body mass index among adults: United States, 1999–2000 through 2015–2016. Natl Health Stat Report 122:1–16
Starling S (2021) FAPs linked with muscle degeneration in T2DM. Nat Rev Endocrinol
Justice JN et al (2018) Cellular senescence biomarker p16INK4a+ cell burden in thigh adipose is associated with poor physical function in older women. J Gerontol Ser A Biol Sci Med Sci 73(7):939–945
Anderson DE et al (2015) Associations of computed tomography-based trunk muscle size and density with balance and falls in older adults. J Gerontol Ser A 71(6):811–816
Barbalho ER et al (2019) Is skeletal muscle radiodensity able to indicate physical function impairment in older adults with gastrointestinal cancer? Exp Gerontol 125:110688
Williams GR et al (2017) Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia? Oncotarget 8(20):33658–33665
Hicks GE et al (2005) Cross-sectional associations between trunk muscle composition, back pain, and physical function in the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 60(7):882–887
Duan-Porter W et al (2016) Physical resilience of older cancer survivors: an emerging concept. J Geriatr Oncol 7(6):471–478
Muresan BT et al (2019) Measurement of body composition in cancer patients using CT planning scan at the third lumbar vertebra. Nutr Hosp 36(6):1307–1314
Acknowledgements
The authors would like to acknowledge Kelsey Smith, PA, for her tireless efforts to provide excellent care to these patients.
Funding
This work was supported by the National Cancer Institute Cancer Center Support Grant (5P30CA016056-42). ALS was funded by the National Cancer Institute Interdisciplinary Training in Cancer Epidemiology Grant (T32CA113951). Funding source had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
Author information
Authors and Affiliations
Contributions
Conceptualization: A.L.S., A.D.R., M.E.P., and K.N.; methodology: A.L.S., G.W., H.O.B., A.D.R., and A.K.S.; software: A.K.S.; formal analysis: A.L.S.; resources: A.K.S., A.D.R., and M.E.P.; data curation: A.L.S., K.E., E.W., A.D.R., A.K.S., and M.E.P.; writing—original draft preparation: A.L.S., M.E.P., G.W., H.O.B., A.D.R., and K.N.; writing—review and editing: A.L.S., M.E.P., G.W., H.O.B., A.D.R., K.N., and A.K.S.; supervision: A.K.S., A.D.R., M.E.P., K.N.; project administration: A.L.S., A.D.R., K.N., M.E.P., and A.K.S.; funding acquisition: A.L.S., A.D.R., and A.K.S. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of Roswell Park Comprehensive Cancer Center (EDR-103707 2/28/2018 l).
Consent to participate
A waiver of consent was obtained from the Institutional Review Board due to the retrospective nature of the study making consent impractical and contacting patients to obtain consent would pose a greater risk than the waiver.
Consent for publication
Consent for publication was obtained.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shaver, A.L., Noyes, K., Platek, M.E. et al. Cross-sectional analysis of myosteatosis and physical function in pretreatment head and neck cancer patients. Support Care Cancer 30, 3401–3408 (2022). https://doi.org/10.1007/s00520-022-06808-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-022-06808-x